bottom line ew controversi stock head print like
disappoint case sound repetit time buy ew pullback
investor get one wednesday morn revenu
ahead street ep surpass street
manag reiter revenu top end rang rais ep
guidanc bug investor tavr revenu reiter
outperform rate ew share
happen quarter ew report revenu includ
tavr sale underli street surgic
heart valv therapi sale ahead street
critic sale well ahead street gross
margin compress y/i sg declin
 combin oper margin flat versu
lower tax rate help versu model deliv ep
versu street
revenu guidanc versu street ep
versu manag re-affirmed revenu high end
versu rais ep versu
tax rate lower contribut mid-point off-set
increas spend sg invest
hot topic ultra ce mark approv expect upon complet small
clinic trial centera sale begun europ ce mark februari
expect price premium sapien manag receiv fda
approv begin centera trial enrol begin
harpoon program paus follow mitral regurgit complic
subject cardioband sale given integr suppli chain
edward system guidanc remain risk sapien
approv remain track chang royalti creat
increas ep
pleas refer page import disclosur includ analyst certif
edward lifesci continu deliv strong
thv sale base indic avail
sapien devic high risk patient provid
volum benefit physician combin
faster market adopt intermedi risk patient
